FDA approves nine generic versions of Pfizer’s Lyrica
July 23, 2019Manufacturing and Production, Sales and Marketing FDA, Lyrica, Pfizer, pharma
The FDA has given its approval to the first generic versions of Pfizer’s Lyrica (pregabalin), it has emerged, giving the …
Acadia’s schizophrenia drug flops in Phase 3 trial
July 23, 2019Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia
Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …
Gilead buys Novartis’ herpes, flu and cold virus preclinical programmes
July 23, 2019Manufacturing and Production Gilead, Novartis, antivrial, deal, herpes, influenza, rhinovirus
Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to treat …
FDA knocks back Biohaven’s ALS drug over manufacturing concerns
July 22, 2019Sales and Marketing Biohaven, FDA, Nurtec, amyotrophic lateral sclerosis, pharma
Biohaven Pharmaceutical has seen its new therapy formulation for the treatment of amyotrophic lateral sclerosis (ALS) rejected by the FDA, …
NICE to review its decision making processes
July 22, 2019Sales and Marketing Cost, NHS, NICE, UK, britain, pharma
Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …
Celgene’s Otezla becomes first and only FDA-approved therapy for oral ulcers in Behçet’s Disease
July 22, 2019Sales and Marketing Behçet's disease, Behçet’s Disease, Celgene, apremilast, otezla, pharma
Celgene has revealed the US approval of Otezla (apremilast), confirming that the FDA awarded marketing authorisation for the treatment of …
Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world
July 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan
The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …
Government spend £9.2 billion on private healthcare providers for NHS in 2018-19
July 22, 2019Sales and Marketing DHSC, NHS, UK, health, healthcare, politics, private providers
The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March …
Ohio prosecutors file charges against opioid distributor Miami-Luken
July 22, 2019Sales and Marketing US, USA, West Virginia, criminal case, opioid crisis, opioids
Federal prosecutors in Cincinnati have filed criminal charges against opioid distributor Miami-Luken, and four others, over the role they played …
Number of UK animal testing procedures falls to lowest level since 2007
July 19, 2019Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch
A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …
Top Ten most popular articles on Pharmafile.com this week!
July 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma
On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
A decade after US approval, Novartis’ Gilenya scores marketing authorisation in China for relapsing multiple sclerosis
July 19, 2019Medical Communications, Sales and Marketing Novartis, gilenya, multiple sclerosis, pharma
Novartis has revealed that its disease modifying drug Gilenya (fingolimod) has secured approval in China for the treatment of relapsing …
DRC rules out trialling experimental Ebola vaccines
July 19, 2019Medical Communications Congo, DRC, Ebola, Ebola vaccine, pharma
The Democratic Republic of Congo (DRC) has said it will stick with Merck’s rVSV-ZEBOV ebola vaccine, as it ruled out …
Royal Pharmaceutical Society in Scotland says contingency plans do not mitigate risk of no-deal Brexit
July 19, 2019Medical Communications RPS, brexit, no-deal Brexit, pharma, pharmaceuticals
The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …
Dr John McHutchinson steps down from Gilead with $1.1 million goodbye
July 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …
“Little to no progress” made in achieving gender representation within top pharma firms, report says
July 18, 2019Manufacturing and Production, Medical Communications female representation, gender equality, pharma
The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” …
FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections
July 18, 2019Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …
Novartis CEO sets aside $700 million to settle bribery lawsuit
July 18, 2019Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …
WHO declares global public health emergency over Ebola outbreak in Congo
July 18, 2019Medical Communications DRC, Democratic Republic of Congo, Ebola, WHO, pharma
The World Health Organization (WHO) has said the Ebola outbreak in the Democratic Republic of Congo (DRC) is a global …
Louvre takes down all references to Purdue-owning Sackler family
July 17, 2019Medical Communications Art, Louvre, PR, Purdue Pharma, Sacklers, donations
The Louvre taken down references to the Sacklers, the billionaire owners of Purdue Pharma. The largest art gallery in the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
